BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
213 hedge funds and large institutions have $2.84B invested in Blueprint Medicines in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 91 increasing their positions, 61 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 33
28% less call options, than puts
Call options by funds: $15.8M | Put options by funds: $21.8M
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
213
Holding in Top 10
2
Calls
$15.8M
Puts
$21.8M
Top Buyers
| 1 | +$29.2M | |
| 2 | +$18.5M | |
| 3 | +$15.6M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$15M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$9.25M |
Top Sellers
| 1 | -$36.3M | |
| 2 | -$23.2M | |
| 3 | -$21M | |
| 4 |
Millennium Management
New York
|
-$12.2M |
| 5 |
NI
Nextech Invest
Zurich,
Switzerland
|
-$8.25M |